THE European Medicines Agency
has announced the commencement
of a review into the safety of
somatropin-containing medicines.
According the EMA the review
was sparked by the results of a
long-term epidemiological study
highlighted by the French medicines
agency, which involved patients
treated during childhood with
somatropin-containing medicines.
The results of the study
suggested an increased risk of
mortality with somatropin therapy
compared to the general population,
particularly when doses were
higher than recommended in the
Summary of Product Characteristics.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Dec 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Dec 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.